Hua Hua
Directeur/Membre du Conseil chez Infervision Medical Technology Co., Ltd.
Profil
Hua Hua is an Independent Non-Executive Director at Infervision Medical Technology Co., Ltd.
since 2020.
Prior to this, Dr. Hua worked as the General Manager & Director at Penn Wharton Consulting Beijing Co. Ltd.
from 2017 to 2019, as the Chief Information Technology Officer at China Investment Corp.
from 2007 to 2017, and as the Deputy General Manager at Changsoft International Beijing Co. Ltd.
from 2003 to 2007.
Dr. Hua received a doctorate degree from The Wharton School of the University of Pennsylvania in 1994, a graduate degree from the University of Pennsylvania in 1987, and an undergraduate degree from Tsinghua University in 1982.
Postes actifs de Hua Hua
| Sociétés | Poste | Début |
|---|---|---|
Infervision Medical Technology Co., Ltd.
 Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China. | Directeur/Membre du Conseil | 10/11/2020 |
Anciens postes connus de Hua Hua
| Sociétés | Poste | Fin |
|---|---|---|
| Penn Wharton Consulting Beijing Co. Ltd. | Directeur Général | 01/07/2019 |
China Investment Corp.
 China Investment Corp. Financial ConglomeratesFinance China Investment Corp. (CIC) is a wholly state-owned investment institution which was established in 2007 under the Company Law of the People's Republic of China to hold, manage and invest their mandated assets to maximize shareholder's value. Headquartered in Beijing, CIC's activities include domestic investments in debt securities denominated in foreign currencies and other financial products denominated in foreign currencies; overseas investments in debt securities, stocks, funds and derivative instruments and other financial products; domestic and overseas equity investments; overseas investments through external fund managers; provision of loans through entrusted financial institutions; management of entrusted foreign exchange assets; establishment of equity investment funds and fund management companies as a promoter and other businesses approved by the relevant governmental authorities. The firm invests in domestic financial institutions primarily through their wholly-owned subsidiary, Central Huijin Investment Ltd. While they operate independently, CIC remains accountable to the State Council of the People's Republic of China and, ultimately, to the citizens of the People's Republic of China. Their investments are not limited to any particular sector, geography or asset class and include equity, fixed-income and alternative assets. | Directeur Technique/Scientifique/R&D | 01/03/2017 |
| Changsoft International Beijing Co. Ltd. | Corporate Officer/Principal | 01/08/2007 |
Formation de Hua Hua
| University of Pennsylvania | Graduate Degree |
| Tsinghua University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
China Investment Corp.
China Investment Corp. Financial ConglomeratesFinance China Investment Corp. (CIC) is a wholly state-owned investment institution which was established in 2007 under the Company Law of the People's Republic of China to hold, manage and invest their mandated assets to maximize shareholder's value. Headquartered in Beijing, CIC's activities include domestic investments in debt securities denominated in foreign currencies and other financial products denominated in foreign currencies; overseas investments in debt securities, stocks, funds and derivative instruments and other financial products; domestic and overseas equity investments; overseas investments through external fund managers; provision of loans through entrusted financial institutions; management of entrusted foreign exchange assets; establishment of equity investment funds and fund management companies as a promoter and other businesses approved by the relevant governmental authorities. The firm invests in domestic financial institutions primarily through their wholly-owned subsidiary, Central Huijin Investment Ltd. While they operate independently, CIC remains accountable to the State Council of the People's Republic of China and, ultimately, to the citizens of the People's Republic of China. Their investments are not limited to any particular sector, geography or asset class and include equity, fixed-income and alternative assets. | Finance |
Infervision Medical Technology Co., Ltd.
Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China. | Technology Services |
| Changsoft International Beijing Co. Ltd. | |
| Penn Wharton Consulting Beijing Co. Ltd. |
